KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Free Cash Flow (2016 - 2025)

Thermo Fisher Scientific's Free Cash Flow history spans 17 years, with the latest figure at $3.0 billion for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 6.48% year-over-year to $3.0 billion, compared with a TTM value of $6.3 billion through Dec 2025, down 13.4%, and an annual FY2025 reading of $6.3 billion, down 13.4% over the prior year.
  • Free Cash Flow for Q4 2025 was $3.0 billion at Thermo Fisher Scientific, up from $1.8 billion in the prior quarter.
  • The five-year high for Free Cash Flow was $3.3 billion in Q4 2023, with the low at $271.0 million in Q2 2023.
  • Average Free Cash Flow over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2021.
  • Year-over-year, Free Cash Flow surged 1210.68% in 2021 and then crashed 82.65% in 2023.
  • Tracing TMO's Free Cash Flow over 5 years: stood at $1.6 billion in 2021, then skyrocketed by 80.63% to $2.9 billion in 2022, then increased by 12.97% to $3.3 billion in 2023, then dropped by 15.31% to $2.8 billion in 2024, then grew by 6.48% to $3.0 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Free Cash Flow are $3.0 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.1 billion (Q2 2025).